Does TERAZOSIN Cause Therapeutic product effect incomplete? 75 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Therapeutic product effect incomplete have been filed in association with TERAZOSIN (terazosin). This represents 14.1% of all adverse event reports for TERAZOSIN.
75
Reports of Therapeutic product effect incomplete with TERAZOSIN
14.1%
of all TERAZOSIN reports
0
Deaths
57
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From TERAZOSIN?
Of the 75 reports, 57 (76.0%) required hospitalization, and 14 (18.7%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Asthma (66)
Dyspnoea (60)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
Hypotension (36)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which TERAZOSIN Alternatives Have Lower Therapeutic product effect incomplete Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE